IRIS
SALTINI, CESARE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.026
EU - Europa 2.165
AS - Asia 563
SA - Sud America 9
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
Totale 22.785
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.011
DE - Germania 654
UA - Ucraina 395
CN - Cina 383
IT - Italia 262
IE - Irlanda 217
FR - Francia 159
SE - Svezia 145
GB - Regno Unito 120
FI - Finlandia 98
KR - Corea 88
RU - Federazione Russa 46
IN - India 30
PL - Polonia 15
RO - Romania 15
JP - Giappone 14
BE - Belgio 13
CA - Canada 10
VN - Vietnam 9
EU - Europa 7
AU - Australia 6
BR - Brasile 6
IL - Israele 6
KG - Kirghizistan 6
LY - Libia 6
NL - Olanda 5
BG - Bulgaria 4
HK - Hong Kong 4
MX - Messico 4
CH - Svizzera 3
ES - Italia 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
HU - Ungheria 2
IQ - Iraq 2
IR - Iran 2
PE - Perù 2
RS - Serbia 2
SA - Arabia Saudita 2
SG - Singapore 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
ID - Indonesia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MA - Marocco 1
NO - Norvegia 1
PH - Filippine 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 22.785
Salva come PNG Salva come JPEG
Città #
Woodbridge 6.450
Wilmington 5.034
Houston 4.482
Ann Arbor 717
Fairfield 569
Jacksonville 390
Chandler 331
Ashburn 287
Seattle 228
Dublin 215
Cambridge 211
Beijing 184
Medford 168
Dearborn 164
Rome 91
Lawrence 83
New York 81
Zhengzhou 61
Menlo Park 50
Mülheim 47
Hangzhou 41
San Diego 37
Milan 24
Boardman 23
Guangzhou 20
San Mateo 19
Redwood City 18
Verona 18
Falls Church 17
University Park 17
Helsinki 16
Nanjing 16
Norwalk 16
Los Angeles 14
Brussels 13
Shanghai 13
Kraków 12
Palo Alto 12
Mountain View 10
Detroit 9
Hefei 8
Kunming 8
London 8
Auburn Hills 7
Liverpool 7
Mcallen 7
Dong Ket 6
Fremont 6
Shirwal 5
Toronto 5
Delhi 4
East Haven 4
Gharyan 4
Jinan 4
Pescara 4
Seoul 4
Sofia 4
Washington 4
Bengaluru 3
Chicago 3
Chula Vista 3
Columbia 3
Hanoi 3
Hanover 3
Highlands Ranch 3
Mexico City 3
Monza 3
New Delhi 3
Pune 3
Saint Petersburg 3
Stockholm 3
Wanchai 3
Yellow Springs 3
Amherst 2
Anagni 2
Anderson 2
Aprilia 2
Arezzo 2
Baghdad 2
Bicester 2
Bologna 2
Chengdu 2
Chester 2
Collegeville 2
Cormano 2
Duncan 2
Fuzhou 2
Granite Bay 2
Herzliya 2
Hughson 2
Imperia 2
Indiana 2
Istanbul 2
Lakeland 2
Lima 2
Lucknow 2
Marseille 2
Meppel 2
Montreal 2
Morgantown 2
Totale 20.406
Salva come PNG Salva come JPEG
Nome #
Idiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in Italy 566
Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study 491
Awake thoracoscopic biopsy of interstitial lung disease 448
Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection 434
Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection 428
A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD 425
Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity 413
null 405
Metodo per la diagnosi in vitro di fibrosi polmonare/polmonite interstiziale idiopatica e uso di chelanti del ferro per il trattamento della fibrosi polmonare/polmonite interstiziale idiopatica 403
Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom 399
Randomized comparison of awake nonresectional versus nonawake resectional lung volume reduction surgery. 399
Transcriptional profile of the immune response in the lungs of patients with active tuberculosis 398
M. avium binding to HLA-DR expressed alleles in silico: A model of phenotypic susceptibility to sarcoidosis 393
A model of phenotypic susceptibility to tuberculosis: Deficient in silico selection of Mycobacterium tuberculosis epitopes by HLA alleles 391
Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity 390
Lysophosphatidic acid enhances antimycobacterial activity both in vitro and ex vivo 385
Expansion of CCR5+ CD4+ T-lymphocytes in the course of active pulmonary tuberculosis 385
Metabolic syndrome and risk of pulmonary involvement 384
Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test 381
Evaluation of a western blot test as a potential screening tool for occupational exposure to Mycobacterium tuberculosis in health care workers 380
HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema 377
Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69 372
Iron laden macrophages in idiopathic pulmonary fibrosis: The telltale of occult alveolar hemorrhage? 369
HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells 364
Use of discriminant analysis to assess disease activity in pulmonary tuberculosis with a panel of specific and nonspecific serum markers 361
Does sphingosine 1-phosphate play a protective role in the course of pulmonary tuberculosis? 359
Analysis of TNF-alpha promoter polymorphisms in the susceptibility to beryllium hypersensitivity 357
Uso di peptidi marcatori di sopravvivenza di Mycobacterium tuberculosis per la diagnosi e la prevenzione di infezione tubercolare e relativo kit diagnostico. 357
Sensitivity and specificity of a multi-antigen ELISA test for the serological diagnosis of tuberculosis 355
Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells 353
Biomarkers of lung damage associated with tobacco smoke in induced sputum 353
Neuroendocrine changes involved in the genesis of HD-induced orthostatic intolerance 348
Synthetic peptides for use in the diagnosis and therapy of chronic granulomatous beryllium disease 347
A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD 346
Immunogenetic basis of environmental lung disease: Lessons from the berylliosis model 340
Peptidi antigenici per uso diagnostico e di vaccinazione anti-tubercolare 340
Uso di sequenze amminoacidiche da Mycobacterium tuberculosis o dei loro corrispondenti acidi nucleici per la diagnosi e la prevenzione di infezione tubercolare, relativo kit diagnostico e vaccino 338
Early abnormalities of the antibody response against Mycobacterium tuberculosis in human immunodeficiency virus infection 334
Beryllium disease 334
Major histocompatibility locus genetic markers of beryllium sensitization and disease 332
Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69 332
Evaluation of a multi-antigen test based on B-cell epitope peptides for the serodiagnosis of pulmonary tuberculosis 329
Serum CA 15-3 is increased in pulmonary fibrosis. 328
Antibody repertoire against the A60 antigen complex during the course of pulmonary tuberculosis 326
New perspectives in the treatment of idiopathic pulmonary fibrosis 320
Inactivation of polymerase inhibitors for Mycobacterium tuberculosis DNA amplification in sputum by using capture resin 320
[Mycobacterium tuberculosis. From the gene to the diagnosis] 319
Serological markers predicting tuberculosis in human immunodeficiency virus-infected patients 319
Head-down bed rest reduces the breathing rate short-term variability in subjects with orthostatic intolerance 312
Evaluation of a western blot serum test for the diagnosis of Mycobacterium tuberculosis infection 311
Predicting survival in newly diagnosed idiopatic pulmonary fibrosis : a 3 years prospective study 307
Method for in vitro diagnosis of idiopathic pulmonary fibrosis 304
QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigens. 277
Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease 275
Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells 275
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. 182
Novel approaches to the treatment of bacterial lower respiratory tract infections: Introduction 141
Chemotherapy and diagnosis of tuberculosis 140
An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease 133
Molecular diagnosis of fatal Nocardia farcinica pneumonia in an HIV-negative patient 132
Autonomic nervous system dysfunction in the course of active pulmonary tuberculosis 131
Difficult diagnosis of infliximab-related miliary tuberculosis 120
An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease 116
HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease 114
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000 106
Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis 105
Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: A meta-analysis 105
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. 104
Markers of anti-oxidant response in tobacco smoke exposed subjects: a data-mining review. 101
Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good. 100
Immunogenetics of severe respiratory infections: Models for the development of new therapeutic strategies 99
Diagnostic accuracy of in-house PCR for pulmonary tuberculosis in smear-positive patients: Meta-analysis and metaregression 93
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial 93
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial. 91
Mycobacterium tuberculosis complex drug resistance in Italy 89
Massive haemoptysis from an aberrant bronchial artery in a patient with cavitary pulmonary tuberculosis 88
Cost determinants of tuberculosis management in a low-prevalence country 85
Predictive valdue of BAL cellular analysis in differentiating pulmonary tuberculosis and sarcoidosis (multiple letters) [3] 80
Schedule or dosage? The need to perfect intermittent regimens for tuberculosis 70
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. 68
Interstitial lung disease induced by exogenous agents: factors governing susceptibility 66
In pursuit of tuberculosis in the pleural space: What more is required? [3] (multiple letters) 62
HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosis 27
Totale 22.829
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.115
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.216 0 0 0 0 0 0 0 0 0 0 598 618
2019/20205.883 498 489 427 550 518 649 502 548 493 494 305 410
2020/20213.226 318 438 316 436 263 317 446 291 110 54 180 57
2021/2022808 17 81 57 70 21 95 39 31 54 85 53 205
2022/2023961 98 64 14 150 86 238 84 44 81 6 74 22
2023/2024319 58 15 44 7 22 103 17 17 21 13 2 0
Totale 22.829